Atlas Trials

GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy

Clinical trial NCT04129008 · UNKNOWN

Trial details

NCT number
NCT04129008
Sponsor
Beijing Anzhen Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery DiseaseGastroesophageal Reflux Disease
Start date
2019-10-17
Primary completion
2020-09-30
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.